Podcast appearances and mentions of matt lamkin

We're very excited to have the musician, surfer, and nature enthusiast, Matt Lamkin, on the podcast. Matt has just released his latest album, Dirty Job, the second of his solo career. In addition to talking about his new album we're going to explore the role nature plays in his creative process and how both nature and music can play a positive role in our mental health. SHOW NOTES: Matt Lamkin Spotify: https://open.spotify.com/artist/39w5Sb2ixdewzZAX6MJ6Jw Matt Lamkin BandCamp: https://mattlamkin.bandcamp.com/ CREDITS: Intro and Outro Song: The Soft Pack - Mexico

In this episode we talk with artist, musician, and all around amazing dude, Matt Lamkin, and explore the role nature and wellness plays in his creativity process. SHOW NOTES: Matt Lamkin on Spotify: https://open.spotify.com/artist/39w5Sb2ixdewzZAX6MJ6Jw CREDITS: Intro and Outro Song: The Soft Pack - Mexico

Hank Greely, Jake Sherkow,and Matt Lamkin discuss a recent Supreme Court decision involving Monsanto, the MERS virus, attempts to patent the gut microbiome, and de-extinction.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss race issues in genetic testing, the myth of anonymity in genetic donation, and the prospects for "bringing back" the Neanderthal.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss the Supreme Court cases Bowman v. Monsanto, Mutual Pharmaceutical v. Bartlett, FTC v. Watson, Maryland v. King, and Association for Molecular Pathology v. Myriad.

Hank Greely discusses recent attempts to introduce FMRI-based lie detection as courtroom evidence; Jake Sherkow analyzes a recent appellate court decision about "pay to delay" settlements between name brand drug companies and generic manufacturers; and Matt Lamkin argues against proposals to expand regulatory oversight of "enhancement" technologies. (September 13, 2012)

Hank Greely, Jake Sherkow, and Matt Lamkin discuss DNA collection statutes, children with three parents, gene therapy for clinical use, and how the biosciences are implicated in the election.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss fMRI lie-detection services, pay-to-delay settlements between branded pharmaceutical and generics companies, and the arguments against increased regulation of enhancement technologies.

Hank Greely and Matt Lamkin, in the inaugural podcast discuss the tension between promoting healthy behaviours and obtaining informed consent, recent developments in forensic DNA, and an upcoming conference at Stanford about prenatal genetic testing.